Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 plus program), Institute for the BioCentury, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 plus program), Institute for the BioCentury, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; Bioinformatics Research Center, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; BioProcess Engineering Research Center, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
Metab Eng. 2017 May;41:82-91. doi: 10.1016/j.ymben.2017.04.001. Epub 2017 Apr 5.
Microbial production of chemicals and materials from renewable sources is becoming increasingly important for sustainable chemical industry. Here, we report construction of a new and efficient platform metabolic pathway for the production of four-carbon (butyrolactam), five-carbon (valerolactam) and six-carbon (caprolactam) lactams. This pathway uses ω-amino acids as precursors and comprises two steps. Activation of ω-amino acids catalyzed by the Clostridium propionicum β-alanine CoA transferase (Act) followed by spontaneous cyclization. The pathway operation was validated both in vitro and in vivo. Three metabolically engineered Escherichia coli strains were developed by introducing the newly constructed metabolic pathway followed by systems-level optimization, which resulted in the production of butyrolactam, valerolactam and caprolactam from renewable carbon source. In particular, fed-batch fermentation of the final engineered E. coli strain produced 54.14g/L of butyrolactam in a glucose minimal medium. These results demonstrate the high efficiency of the novel lactam pathway developed in this study.
微生物利用可再生资源生产化学品和材料对于可持续化学工业变得越来越重要。在这里,我们报告了一种生产四碳(丁内酰胺)、五碳(戊内酰胺)和六碳(己内酰胺)内酰胺的新型高效平台代谢途径的构建。该途径以ω-氨基酸为前体,包含两个步骤。由丙酸梭菌β-丙氨酸辅酶 A 转移酶(Act)催化的ω-氨基酸的激活,然后自发环化。该途径的操作在体外和体内都得到了验证。通过引入新构建的代谢途径并进行系统水平的优化,开发了三种代谢工程大肠杆菌菌株,从而可以从可再生碳源生产丁内酰胺、戊内酰胺和己内酰胺。特别是,最终工程大肠杆菌菌株的分批补料发酵在葡萄糖最小培养基中生产了 54.14g/L 的丁内酰胺。这些结果表明,本研究中开发的新型内酰胺途径具有很高的效率。